ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,128.00
      0.62%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      82.095
      -0.22%
      Bitcoin
      67,208.86
      -1.39%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Jasper Therapeutics Inc (JSPR)

      7. Jasper Therapeutics Inc (JSPR) Financials

      Jasper Therapeutics Inc

      Jasper Therapeutics Inc (JSPR)

      NASDAQ
      20.24
      -0.68
      (-3.25%)
      Closed July 19 4:00PM
      Delayed by 15 minutes
      20.24
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Jasper Therapeutics Inc Financial Summary

      The current JSPR market cap is 305.33M. The company's latest EPS is USD -4.2733 and P/E is -4.74.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -13.95M-17.83M-19.36M-17.73M-15.07M
      Net Income -14.26M-16.08M-17.54M-16.58M-13.73M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -136k-935k-36.83M-51.2M-68.86M
      Net Income 2k-591k-30.64M-37.69M-64.47M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 138.76M124.17M110.41M94.89M125.96M
      Total Liabilities 13.56M13.97M16.27M16.45M12.73M
      Total Equity 125.2M110.21M94.13M78.44M113.23M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 101.69M101.26M93.65M48.36M94.89M
      Total Liabilities 3.61M3.77M24.14M12.37M16.45M
      Total Equity 5M5M69.52M35.99M78.44M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -10.34M-23.61M-35.59M-52.07M-15.74M
      Investing -26k-37k-37k-267k-25k
      Financing 101.51M101.21M101.24M100.97M47.35M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -367k-641k-33.68M-45.86M-52.07M
      Investing -100M198k-2.43M-576k-267k
      Financing 101.58M N/A 100.97M55k100.97M

      Stats and Ratios

      Market Cap 305.33M
      Price to Earnings Ratio -4.74
      Price to Sales Ratio 0
      Price to Cash Ratio 3.51
      Price to Book Ratio 3.89
      Dividend Yield -

      Share Statistics

      Shares Outstanding 15.09M
      Average Volume (1 week) 220.76k
      Average Volume (1 Month) 248.36k
      52 Week Change 38.63%
      52 Week High 31.01
      52 Week Low 4.00
      Spread (Intraday) 2.42 (11.2%)

      Company Info

      Company Name Jasper Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.jaspertherapeutics.com
      Industry biological pds,ex diagnstics (2836)